Skip to main content
OpenTrials
Completed

NCT Number: NCT04251338

Delayed Visual Maturation: Outcome and Predictive Factors

The objectives of the study are to describe the developmental outcome in a population of children with delayed visual maturation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Delayed Visual Maturation

Age range

3 month–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitaire Ziekenhuizen Leuven

Leuven, 3000, Belgium

About this study

description of the developmental outcome of children with delayed visual maturation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infants (male or female) with suboptimal/absent visual contact at the age of ≥3 months, without other known general developmental delay at the time diagnosis of delayed visual contact and without anatomic ocular abnormalities at the initial ophthalmological examination.

Exclusion criteria

  • Children with known underlying psychomotor developmental delay or epilepsy at first ophthalmic consultation.
  • Children with ophthalmic (anatomical) abnormalities that explain delayed visual maturation.

Treatment and study plan

Primary outcomes

  1. delayed visual maturation.

    Time frame: 1998-2016

    the prevalence of developmental problems in children with delayed visual maturation.

Secondary outcomes

  1. Level of development

    Time frame: 1998-2016

    by questionnaire:type of education/school , problems with writing, mathematics: yes or no

  2. Fine and gross motor skills

    Time frame: 1998-2016

    by questionnaire: physiotherapy needed yes or no

  3. ophthalmological problems

    Time frame: 1998-2016

    by questionnaire : visual problems, wearing glasses? taped eyes?

  4. Visual acuity

    Time frame: 1998-2016

    assested at the last consultation indicated in Snellen

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Acronym: DVM

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jan 31, 2020
Registry last updated
May 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.